or Try an Advanced Search...

    Technical Analysis for VERA - Vera Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 37.99 2.81% 1.04
    VERA closed up 2.81 percent on Friday, May 31, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical VERA trend table...
    Date Alert Name Type % Chg
    Pocket Pivot Bullish Swing Setup 0.00%
    Spinning Top Other 0.00%
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    Hammer Candlestick Bullish 2.81%
    NR7 Range Contraction 2.81%
    NR7-2 Range Contraction 2.81%
    Older End-of-Day Signals for VERA ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 1 day ago
    10 DMA Resistance 1 day ago
    60 Minute Opening Range Breakout 1 day ago
    Up 3% 1 day ago
    Up 2% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    VERA Chart by TradingView
    Basic chart:

    Profile

    Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Health Care

    Is VERA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 31 Wall Street Snaps Five-Week Winning Streak, Economic Growth Slows, Inflation Holds Steady In April: This Week In The Market
    May 29 Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker
    May 28 Vera gains FDA Breakthrough Therapy Designation for atacicept
    May 28 Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN)
    May 25 Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
    May 9 Vera Therapeutics GAAP EPS of -$0.56
    May 9 Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
    May 7 Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    May 6 Vera Therapeutics, Inc.'s (NASDAQ:VERA) high institutional ownership speaks for itself as stock continues to impress, up 5.0% over last week
    Apr 23 Health Care Roundup: Market Talk
    See more VERA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 50.78
    52 Week Low 7.73
    Average Volume 975,435
    200-Day Moving Average 26.58
    50-Day Moving Average 40.98
    20-Day Moving Average 40.62
    10-Day Moving Average 38.35
    Average True Range 2.50
    RSI (14) 41.86
    ADX 14.16
    +DI 17.44
    -DI 21.79
    Chandelier Exit (Long, 3 ATRs) 41.00
    Chandelier Exit (Short, 3 ATRs) 43.42
    Upper Bollinger Bands 46.23
    Lower Bollinger Band 35.00
    Percent B (%b) 0.27
    BandWidth 27.65
    MACD Line -1.24
    MACD Signal Line -0.84
    MACD Histogram -0.3979
    Fundamentals Value
    Market Cap 2.04 Billion
    Num Shares 53.7 Million
    EPS -2.86
    Price-to-Earnings (P/E) Ratio -13.28
    Price-to-Sales 0.00
    Price-to-Book 16.31
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 39.87
    Resistance 3 (R3) 39.79 39.10 39.55
    Resistance 2 (R2) 39.10 38.62 39.13 39.45
    Resistance 1 (R1) 38.54 38.32 38.82 38.62 39.34
    Pivot Point 37.85 37.85 37.99 37.88 37.85
    Support 1 (S1) 37.29 37.37 37.57 37.37 36.64
    Support 2 (S2) 36.60 37.07 36.63 36.53
    Support 3 (S3) 36.04 36.60 36.43
    Support 4 (S4) 36.12